Published by Josh White on 12th March 2019
(Sharecast News) - Gene and cell therapy company Oxford Biomedica has entered into a research and development collaboration with Microsoft Research, it announced on Tuesday, to improve the yield and quality of next-generation gene therapy vectors using the cloud and machine learning.
URL: http://www.digitallook.com/dl/news/story/28748165/...